Document Detail


Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
MedLine Citation:
PMID:  18343646     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been documented that tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists (LABAs) and combined administration of a LABA and an inhaled corticosteroid (ICS) reduces the potential for acute effects of LABA on blood-gas tensions. In this study, we have compared the acute effects of tiotropium 18 microg and salmeterol/fluticasone combination (SFC) 50/250 microg on arterial blood gases in 20 patients with stable COPD. Each subject was studied on 2 days, separated from one another by at least 4 days. Blood specimens were taken just before the inhalation and at 15, 30, 60, 180 and 360 min after inhalation of each treatment, and spirometry was performed at the same time points. As expected, both treatments significantly improved FEV1 (greatest changes were 0.20 L, 95% CI: 0.13-0.27 at 360 min after tiotropium; and 0.13 L, 95% CI: 0.06-0.19 at 180 min after SFC). The greatest mean changes from baseline in PaO2 were -1.7 (95% CI: -4.0 to 0.6)mmHg, p=0.134, after tiotropium; -0.8 (95% CI: -2.2 to 0.6)mmHg, after SFC. Both changes were observed after 15 min. Both drugs caused a small decrease in PaCO2 (greater changes: -1.9 (95% CI -3.2 to -0.6)mmHg, p=0.005 at 60 min after tiotropium; and -2.4 (95% CI: -3.5 to -1.3) mmHg, p=0.0002 at 180 min after SFC). These results indicate that both tiotropium and SFC are able to induce a significant long-last bronchodilation without affecting arterial blood gases. Moreover, they confirm that the impact of tiotropium on PaO2 is small and without clinical significance and the addition of a LABA to an ICS can reduce the potentially dangerous acute effect of the LABA on blood gases.
Authors:
Filippo Andò; Paolo Ruggeri; Giuseppe Girbino; Mario Cazzola
Related Documents :
6207136 - Retinal oxygen tension and oxygen reactivity in retinopathy of prematurity in kittens.
7930856 - Conjunctival oxygen tension is influenced by plasma and blood volume, and flow through ...
12445826 - Arteriovenous carboxyhemoglobin difference in critical illness: fiction or fact?
3193146 - Comparison of three oxygen monitors in detecting endobronchial intubation.
2871886 - The effects of nisoldipine (bay k 5552) on cardiovascular performance and regional bloo...
3429056 - Differential photoabsorption using argon laser radiation on atherosclerotic plaque in n...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2008-03-17
Journal Detail:
Title:  Respiratory medicine     Volume:  102     ISSN:  0954-6111     ISO Abbreviation:  Respir Med     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-05     Completed Date:  2008-08-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  815-8     Citation Subset:  IM    
Affiliation:
Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / pharmacology,  therapeutic use
Albuterol / analogs & derivatives,  pharmacology,  therapeutic use
Androstadienes / pharmacology,  therapeutic use
Anti-Inflammatory Agents / pharmacology,  therapeutic use
Bronchodilator Agents / pharmacology*,  therapeutic use
Carbon Dioxide / blood
Cross-Over Studies
Drug Combinations
Forced Expiratory Volume / drug effects
Humans
Oxygen / blood*
Partial Pressure
Pulmonary Disease, Chronic Obstructive / blood*,  drug therapy,  physiopathology
Scopolamine Derivatives / pharmacology,  therapeutic use
Vital Capacity / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Androstadienes; 0/Anti-Inflammatory Agents; 0/Bronchodilator Agents; 0/Drug Combinations; 0/Scopolamine Derivatives; 124-38-9/Carbon Dioxide; 136310-93-5/tiotropium; 18559-94-9/Albuterol; 7782-44-7/Oxygen; 89365-50-4/salmeterol; 90566-53-3/fluticasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Articaine interaction with DSPC bilayer: a 13C and 31P solid-state NMR study.
Next Document:  Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with he...